Abstract
Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have